Allegro Diagnostics, Veracyte deal

Veracyte will acquire diagnostic company Allegro for $7.8 million in cash and $13.2 million in Veracyte shares, or about 993,000 shares. Veracyte plans to launch Allegro's BronchoGen genomic test -- ...